Cargando…

Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma

SIMPLE SUMMARY: Hepatoblastoma patients with tumors that do not respond to preoperative chemotherapy often experience incomplete surgical resection and thus poor outcomes. By analyzing the gene expression data of chemoresistant and responsive tumors using sophisticated drug prediction software we id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qian, Demir, Salih, Del Río-Álvarez, Álvaro, Maxwell, Rebecca, Wagner, Alexandra, Carrillo-Reixach, Juan, Armengol, Carolina, Vokuhl, Christian, Häberle, Beate, von Schweinitz, Dietrich, Schmid, Irene, Cairo, Stefano, Kappler, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454988/ https://www.ncbi.nlm.nih.gov/pubmed/36077733 http://dx.doi.org/10.3390/cancers14174196

Ejemplares similares

SP8 Promotes an Aggressive Phenotype in Hepatoblastoma via FGF8 Activation
por: Wagner, Alexandra Elisabeth, et al.
Publicado: (2020)

Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations
por: Regel, Ivonne, et al.
Publicado: (2020)

Erratum: Wagner, A.E., et al. SP8 Promotes an Aggressive Phenotype in Hepatoblastoma via FGF8 Activation. Cancers 2020, 12, 2294
por: Wagner, Alexandra Elisabeth, et al.
Publicado: (2021)

Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma
por: Beck, Alexander, et al.
Publicado: (2018)

IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors
por: Regel, Ivonne, et al.
Publicado: (2012)

Altered expression of members of the IGF-axis in hepatoblastomas
por: Gray, S G, et al.
Publicado: (2000)

Total Psoas Muscle Area as a Marker for Sarcopenia Is Related to Outcome in Children With Neuroblastoma
por: Ritz, Annika, et al.
Publicado: (2021)

Outcomes of Patients Treated for Hepatoblastoma with Low Alpha-Fetoprotein and/or Small Cell Undifferentiated Histology: A Report from the Children’s Hepatic Tumors International Collaboration (CHIC)
por: Trobaugh-Lotrario, Angela D., et al.
Publicado: (2023)

Treatment of echinococcosis: albendazole and mebendazole – what else?
por: Hemphill, Andrew, et al.
Publicado: (2014)

Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma
por: Wang, Huabo, et al.
Publicado: (2021)

Characterisation of Aberrant Metabolic Pathways in Hepatoblastoma Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS)
por: Whitby, Alison, et al.
Publicado: (2023)

Pediatric hepatocellular carcinoma: challenges and solutions
por: Schmid, Irene, et al.
Publicado: (2017)

Efficacy and reinfection with soil-transmitted helminths 18-weeks post-treatment with albendazole-ivermectin, albendazole-mebendazole, albendazole-oxantel pamoate and mebendazole
por: Speich, Benjamin, et al.
Publicado: (2016)

Alternative Splicing of lncRNAs From SNHG Family Alters snoRNA Expression and Induces Chemoresistance in Hepatoblastoma
por: Zhen, Ni, et al.
Publicado: (2023)

Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
por: Nygren, Peter, et al.
Publicado: (2013)

Efficacy of Albendazole and Mebendazole With or Without Levamisole for Ascariasis and Trichuriasis
por: Anto, Endy Juli, et al.
Publicado: (2019)

Preventative Effect of Mebendazole against Malignancies in Neurofibromatosis 1
por: Staedtke, Verena, et al.
Publicado: (2020)

Behavior of Mebendazole during NF/RO Adsorption and Photolysis
por: Babić, Bruna, et al.
Publicado: (2022)

‘Teratoid’ Hepatoblastoma: An Intriguing Variant of Mixed Epithelial-Mesenchymal Hepatoblastoma
por: Sergi, Consolato M., et al.
Publicado: (2022)

Neuropilin-2 Is Associated With Increased Hepatoblastoma Cell Viability and Motility
por: Eloranta, Katja, et al.
Publicado: (2021)

The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors
por: Kolorz, Julian, et al.
Publicado: (2021)

Mebendazole Is a Potential Alternative in the Treatment of Giardia duodenalis Infection
por: Cañete, Roberto
Publicado: (2016)

Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
por: Chai, Jong-Yil, et al.
Publicado: (2021)

Hepatoblastoma : presentación de un caso clínico /
por: Mora Sarmiento, Laura
Publicado: (1988)

Volasertib preclinical activity in high-risk hepatoblastoma
por: Kats, Dina, et al.
Publicado: (2019)

Hepatoblastoma: when to screen?
por: O’Malley, Margaret, et al.
Publicado: (2011)

Hepatoblastoma with Precocious Puberty
por: Yhoshu, Enono, et al.
Publicado: (2019)

The Genetic Changes of Hepatoblastoma
por: Chen, Huitong, et al.
Publicado: (2021)

Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2014)

DNA Damage Response Is Involved in the Developmental Toxicity of Mebendazole in Zebrafish Retina
por: Sasagawa, Shota, et al.
Publicado: (2016)

Safety of Mebendazole Use During Lactation: A Case Series Report
por: Karra, Nour, et al.
Publicado: (2016)

Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
por: Williamson, Tara, et al.
Publicado: (2021)

Exposure of Paracoccidioides brasiliensis to Mebendazole Leads to Inhibition of Fungal Energy Production
por: Rocha, Olivia Basso, et al.
Publicado: (2023)

UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival
por: Nousiainen, Ruth, et al.
Publicado: (2023)

Genetic Disruption of Cilia-Associated Signaling Pathways in Patients with VACTERL Association
por: Ritter, Jessica, et al.
Publicado: (2023)

Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse
por: Brown, Anthony, et al.
Publicado: (2023)

Olaparib Inhibits Tumor Growth of Hepatoblastoma in Patient‐Derived Xenograft Models
por: Johnston, Michael Edward, et al.
Publicado: (2021)

Chloroquine Triggers Cell Death and Inhibits PARPs in Cell Models of Aggressive Hepatoblastoma
por: Eloranta, Katja, et al.
Publicado: (2020)

Perinatal risk factors for hepatoblastoma
por: Spector, L G, et al.
Publicado: (2008)

Hepatoblastoma in Adult: Review of the Literature
por: Zheng, Ming Hua, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_ebguepm6s9u2be3tic5ct228dh